Recent filings

Theravance Biopharma, Inc. insider just disposed of 5,567 shares - May 23, 2023

Theravance Biopharma, Inc. insider just disposed of 10,460 shares - May 23, 2023

Theravance Biopharma, Inc. insider just disposed of 8,744 shares - May 23, 2023

Theravance Biopharma, Inc. insider just disposed of 11,469 shares - May 23, 2023

Theravance Biopharma, Inc. insider just disposed of 15,804 shares - May 23, 2023

Report of proposed sale of securities - May 15, 2023

Theravance Biopharma, Inc. Just Filed Its Quarterly Report: 2. Net Loss per Shar... - May 10, 2023

Current report, items 2.02 and 9.01 - May 8, 2023

Theravance Biopharma, Inc. insider just picked up 9,132 shares - May 4, 2023

Theravance Biopharma, Inc. insider just picked up 9,132 shares - May 4, 2023

Theravance Biopharma, Inc. insider just picked up 9,132 shares - May 4, 2023

Theravance Biopharma, Inc. insider just picked up 9,132 shares - May 4, 2023

Theravance Biopharma, Inc. insider just picked up 9,132 shares - May 4, 2023

Theravance Biopharma, Inc. insider just picked up 9,132 shares - May 4, 2023

Theravance Biopharma, Inc. insider just picked up 9,132 shares - May 4, 2023

Material Modification to Rights of Security - May 3, 2023

Theravance Biopharma, Inc. insider just declared 0 ownership of the company. - April 20, 2023

Theravance Biopharma, Inc. insider just disposed of 2,323 shares - April 18, 2023

Regulation FD - April 17, 2023

Report of proposed sale of securities - April 14, 2023

Weiss Asset Management LP just provided an update on activist position in Theravance Biopharma, Inc. - April 12, 2023

Departure of Directors or Certain - April 11, 2023

Theravance Biopharma: Item 5.02. Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers - April 11, 2023

Theravance Biopharma: Proxy Statement Pursuant To Section 14(A) Of - April 11, 2023

Other definitive proxy statements - March 28, 2023

Other preliminary proxy statements - March 17, 2023

Theravance Biopharma, Inc. insider just disposed of 2,323 shares - March 16, 2023

Theravance Biopharma, Inc. insider just disposed of 2,323 shares - March 8, 2023

Theravance Biopharma, Inc. insider just picked up 80,000 shares - March 3, 2023

Theravance Biopharma, Inc. insider just picked up 75,000 shares - March 3, 2023

Theravance Biopharma, Inc. insider just picked up 75,000 shares - March 3, 2023

Theravance Biopharma, Inc. insider just picked up 330,000 shares - March 3, 2023

Theravance Biopharma, Inc. insider just picked up 75,000 shares - March 3, 2023

Departure of Directors or Certain - March 1, 2023

Theravance Biopharma, Inc. Just Filed Its Annual Report: Net Income (Loss) pe... - March 1, 2023

Theravance Biopharma, Inc. insider just picked up 11,819 shares - Feb. 28, 2023

Theravance Biopharma, Inc. insider just declared 0 ownership of the company. - Feb. 28, 2023

Aziz Sawaf - Theravance Biopharma, Inc. – Cfo Thanks, Rick. - Feb. 28, 2023

Theravance Biopharma, Inc. insider just declared owning 240,156 shares of Theravance Biopharma, Inc. - Feb. 22, 2023

Theravance Biopharma, Inc. insider just disposed of 7,119 shares - Feb. 22, 2023

Theravance Biopharma, Inc. insider just disposed of 37,420 shares - Feb. 22, 2023

Theravance Biopharma, Inc. insider just disposed of 12,057 shares - Feb. 22, 2023

Theravance Biopharma, Inc. insider just disposed of 10,198 shares - Feb. 22, 2023

Theravance Biopharma, Inc. insider just disposed of 6,783 shares - Feb. 22, 2023

Eli Samaha just provided an update on share ownership of Theravance Biopharma, Inc. - Feb. 14, 2023

OrbiMed Advisors LLC just issued a filing suggesting it has sold all of its Theravance Biopharma, Inc. - Feb. 14, 2023

Seth A. Klarman just provided an update on share ownership of Theravance Biopharma, Inc. - Feb. 13, 2023

BlackRock, Inc. just provided an update on share ownership of Theravance Biopharma, Inc. - Feb. 10, 2023

WEISS ASSET MANAGEMENT LP just provided an update on share ownership of Theravance Biopharma, Inc. - Feb. 10, 2023

Barclays PLC just provided an update on share ownership of Theravance Biopharma, Inc. - Jan. 30, 2023

Theravance Biopharma, Inc. insider just declared owning 204,500 shares of Theravance Biopharma, Inc. - Jan. 10, 2023

Current report, items 2.02 and 9.01 - Jan. 9, 2023

Theravance Biopharma, Inc. insider just disposed of 59,000 shares - Dec. 16, 2022

Departure of Directors or Certain - Dec. 12, 2022

Theravance Biopharma, Inc. insider just disposed of 2,084 shares - Dec. 5, 2022

Theravance Biopharma, Inc. insider just disposed of 10,000 shares - Nov. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 90,057 shares - Nov. 22, 2022

Tender offer statement by Issuer - Nov. 22, 2022

Theravance Biopharma, Inc. insider just disposed of 15,804 shares - Nov. 22, 2022

Theravance Biopharma, Inc. insider just disposed of 23,268 shares - Nov. 22, 2022

Theravance Biopharma, Inc. insider just disposed of 27,350 shares - Nov. 22, 2022

Tender offer statement by Issuer - Nov. 18, 2022

Theravance Biopharma, Inc. insider just disposed of 2,800 shares - Nov. 17, 2022

Tender offer statement by Issuer - Nov. 14, 2022

Theravance Biopharma: Unaudited Pro Forma Condensed Consolidated Financial Statements - Nov. 14, 2022

Tender offer statement by Issuer - Nov. 9, 2022

Theravance Biopharma, Inc. Just Filed Its Quarterly Report: 2. Net Income (Loss)... - Nov. 9, 2022

Tender offer statement by Issuer - Nov. 7, 2022

Current report, items 2.02 and 9.01 - Nov. 7, 2022

Current report, items 7.01 and 9.01 - Nov. 3, 2022

Major owner of Theravance Biopharma, Inc. just declared owning 7,012,226 shares of Theravance Biopharma, Inc. - Oct. 21, 2022

Major owner of Theravance Biopharma, Inc. just declared owning 7,457,060 shares of Theravance Biopharma, Inc. - Sept. 28, 2022

Tender offer statement by Issuer - Sept. 28, 2022

Theravance Biopharma, Inc. insider just disposed of 9,644,807 shares - Sept. 20, 2022

GSK plc just issued a filing suggesting it has sold all of its Theravance Biopharma, Inc. - Sept. 20, 2022

As previously reported on the Current Report on Form  - Sept. 20, 2022

Entry into a Material Definitive - Sept. 19, 2022

Written communication relating to an issuer or third party - Sept. 19, 2022

Current report, items 7.01 and 9.01 - Sept. 13, 2022

As previously - Aug. 25, 2022

Tender offer statement by Issuer - Aug. 25, 2022

Theravance Biopharma, Inc. insider just disposed of 25,676 shares - Aug. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 18,991 shares - Aug. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 10,413 shares - Aug. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 15,804 shares - Aug. 23, 2022

Theravance Biopharma, Inc. insider just disposed of 4,906 shares - Aug. 18, 2022

Theravance Biopharma, Inc. insider just disposed of 15,086 shares - Aug. 11, 2022

Theravance Biopharma, Inc. Just Filed Its Quarterly Report: 2. Net Loss per Shar... - Aug. 8, 2022

Tender offer statement by Issuer - Aug. 8, 2022

Tender offer statement by Issuer - Aug. 5, 2022

Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results - Aug. 4, 2022

General statement of acquisition of beneficial ownership - Aug. 3, 2022

Theravance Biopharma, Inc. insider just picked up 20,000 shares - July 27, 2022

Tender offer statement by Issuer - July 26, 2022

Completion of Acquisition or Disposition of - July 20, 2022

Written communication relating to an issuer or third party - July 14, 2022

Entry into a Material Definitive - July 14, 2022

Written communication relating to an issuer or third party - July 13, 2022

Theravance Biopharma To Sell Trelegy Ellipta Royalty Interests To Royalty Pharma For Approximately $1.1 Billion In Upfront Cash With Over $1.5 Billion In Potential Total Value - July 13, 2022

WEISS ASSET MANAGEMENT LP just provided an update on share ownership of Theravance Biopharma, Inc. - June 16, 2022

Sorry, no schedule available for this company